在怀孕期间与代谢功能障碍相关的脂肪性肝病:一篇评论
Daniel Core1, Layne Landry1, Christopher Menefee1
1Resident, Department of OBGYN.
Obstetrical & gynecological survey
|February 19, 2026
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 在怀孕期间很常见,并且与不良结果有关. 早期检测和管理对于母亲和婴儿健康至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD),以前是非酒精性脂肪性肝病,影响了14%的孕妇.
- MASLD与肥胖和胰岛素抵抗等代谢并发症有关.
- 它与妊娠并发症有关,包括妊娠糖尿病和高血压疾病.
研究的目的:
- 审查MASLD的病理生理学,诊断,管理和怀孕并发症.
- 突出怀孕人口中MASLD的患病率和诊断不足的增加.
主要方法:
- 使用Rayyan进行了文献搜索.
- 审查了2000年至2024年间发表的180篇文章.
主要成果:
- 在怀孕期间,MASLD的患病率越来越高,而且在怀孕期间可能被诊断不足.
- 肥胖和怀孕的生理变化可能会使肝硬化症恶化.
- MASLD与不良的怀孕和后代结果有关.
结论:
- 需要进一步的研究,以实现妊娠中MASLD的最佳查,诊断和管理.
- 早期检测可能需要进行糖尿病查和低剂量阿司匹林.
- 对孕产妇发病率,早产和后代代谢疾病等风险的咨询至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
223
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
223
Overview of Lipid Metabolism
5.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
210
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
210
Liver Physiology
3.9K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.9K
Inborn Errors of Metabolism
936
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
936
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
270
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
270


